DEEPHEALTH UK LIMITED

What DEEPHEALTH UK LIMITED does

DeepHealth is the wholly-owned digital health subsidiary of RadNet, Inc. (NASDAQ: RDNT), operating as a cloud-native AI-powered radiology informatics and clinical AI platform. Launched in November 2023 as an umbrella brand consolidating prior RadNet digital health assets (eRAD, Aidence, Quantib, Kheiron, iCAD) and subsequently expanded through the acquisitions of See-Mode (June 2025), CIMAR UK (November 2025), and Gleamer (March 2026, up to €230M), DeepHealth unifies AI-driven detection, radiology informatics, and operational workflows on a single operating system, DeepHealth OS. Its portfolio spans Enterprise Imaging products (Diagnostic Suite with PACS, Operations Suite with RIS, TechLive remote scanning) and Population Health suites for breast, lung, prostate, brain, and thyroid imaging, supported by AI Studio, Reporting Pro, and Patient Engagement modules.

DeepHealth serves hospital systems, national and regional cancer screening programs, independent radiology groups, and imaging center chains, with deployment reach extending to more than 2,890 customers across 50+ countries and 15M+ exams annually. Strategic OEM partnerships with GE HealthCare and Siemens Healthineers embed its AI into major mammography and ultrasound platforms, while AWS Marketplace and a European distribution agreement with Incepto broaden commercial channels. Clinically validated by a Nature Health study (579,583 exams, 21% increase in breast cancer detection) and deployed across 90%+ of NHS England Lung Cancer Screening Program sites, the platform combines 26 FDA-cleared and 22 CE-marked devices spanning 75+ indications.

DeepHealth generates revenue primarily through enterprise SaaS subscriptions, with ARR growing from $49.8M at March 2025 to $96.9M at March 2026 and a stated target of more than $140M by year-end 2026. Q1 2026 Digital Health segment revenue was $29.1M (+51.5% YoY), supplemented by professional services and the Saint Alphonsus/Trinity Health joint venture projected to contribute ~$30M annually. Pricing is quote-based and tailored to deployment scope; ARR is the primary public financial metric, and go-to-market combines direct enterprise field sales, OEM distribution, AWS Marketplace, and event-led demand generation at RSNA, ECR, and SBI.

Name

DEEPHEALTH UK LIMITED

Legal name

DeepHealth Inc.

Website

https://deephealth.com

Company type

Private

Founded year

2023

Operating status

Operating

Short description

DeepHealth, a wholly-owned subsidiary of RadNet (NASDAQ: RDNT), provides cloud-native AI-powered radiology informatics and clinical AI for breast, lung, prostate, brain, and thyroid imaging, serving 2,890+ hospital systems, imaging centers, and national screening programs across 50+ countries.

Ownership category

akta.pro rank

Product category

Medical Imaging AI Software

NAICS

Software Publishers (5132), Software Publishers (513210)

SIC

Services-Health Services (8000), Services-Prepackaged Software (7372)

akta.pro primary industry

AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)

akta.pro secondary industries

Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD), Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web) (HLACALAI), Quality, Peer Review & Compliance Tools (MQSA/ACR/QA) (HLACALAL), Medical Imaging AI (HDAAAEAH)

Keywords

• Radiology AI software
• Medical imaging informatics
• Clinical decision support
• Cancer screening AI
• Enterprise imaging platform

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Subscription / SaaS (Annual Recurring Revenue): DeepHealth operates primarily as a cloud-first SaaS business, generating subscription and recurring revenue from its AI-powered health informatics platform. DeepHealth OS and individual clinical AI suites are delivered as subscription-based SaaS solutions to imaging centers, hospital radiology departments, and health systems globally. The company reports ARR metrics publicly, growing from $49.8M at March 31, 2025 to $96.9M at March 31, 2026, with a target exceeding $140M by year-end 2026. Gleamer's cloud platform also drives a SaaS ARR business model with ARR growth exceeding 90% CAGR from 2022-2025 and ~$30M ARR projected for 2026.
2. Radiology Informatics / Software Licenses: DeepHealth provides radiology information systems (RIS), picture archiving and communication systems (PACS), image management systems, and clinical AI solutions to external radiology practices, imaging center networks, and hospital systems. ONRAD committed to deploying a full suite of DeepHealth OS-powered solutions, representing a named external customer contract. Revenue from the Digital Health segment reached $29.1M in Q1 2026, up 51.5% year-over-year, and $14.7M in Q1 2024, growing 32.3% year-over-year.
3. AI Business (part of Digital Health segment): AI-specific revenue stream within the Digital Health segment, which grew 118% year-over-year in Q1 2024, driven primarily by the rollout of the Enhanced Breast Cancer Detection (EBCD) DeepHealth AI-powered screening mammography program. AI revenue is embedded within the broader subscription/SaaS model.
4. Professional Services & Implementation: DeepHealth provides implementation, integration, and professional services to deploy its solutions at customer sites. This includes integration with existing IT infrastructure, training, and onboarding. Revenue from professional services is excluded from ARR calculations per the company's definition.

Pricing tiers

Go-to-market motion5 records

Distribution channels5 records

Marketing channels7 records

Core offering

DeepHealth develops and sells cloud-native, AI-powered radiology health informatics software used by hospitals, imaging centers, and national cancer screening programs. Its portfolio is unified by DeepHealth OS, a cloud-native operating system that orchestrates clinical AI detection (breast, lung, prostate, brain, thyroid) with PACS/RIS imaging informatics, remote scanning (TechLive), AI orchestration (AI Studio), and AI-augmented reporting (Reporting Pro). Products and subscriptions are sold primarily to enterprise healthcare providers for use in clinical interpretation and large-scale screening workflows.

Product overview

DeepHealth is a radiology AI-powered health informatics company offering a comprehensive portfolio of products organized around a cloud-native operating system (DeepHealth OS) that unifies clinical and operational workflows. The portfolio spans two main categories: Enterprise Imaging solutions (Diagnostic Suite, Operations Suite, and TechLive) for operational efficiency and diagnostic workflows; and Population Health solutions (Breast Suite, Prostate Suite, Chest Suite, Neuro Suite, and Thyroid Suite) for AI-powered cancer screening and disease detection. Supporting capabilities include AI Studio for enterprise AI orchestration, Reporting Pro for automated radiology reporting, and Patient Engagement tools. The company has integrated multiple acquired brands including eRAD, Aidence (Saige Lung), Quantib (Saige Prostate), Kheiron, iCAD, CIMAR UK, See-Mode, and Gleamer to build the industry's most comprehensive native clinical AI portfolio spanning MR, CT, X-ray, Mammography and Ultrasound modalities.

Differentiator

Problem solved

Functional benefit

Brands

• DeepHealth OS: Cloud-native operating system that unifies data across clinical and operational workflow and personalizes AI-powered workspaces
• Diagnostic Suite
• Operations Suite
• TechLive
• Breast Suite
• Chest Suite
• Prostate Suite
• Neuro Suite
• Thyroid Suite
• AI Studio
• SmartMammo

Products and services

• DeepHealth OS Cloud-native operating system that unifies data across clinical and operational workflows and personalizes AI-powered workspaces for everyone in the radiology continuum; serves as the foundational workflow engine for all DeepHealth solutions and integrates proprietary and third-party AI applications via modular, API-based architecture.
• Diagnostic Suite Unified diagnostic workspace with PACS functionality, enhanced viewer, advanced image management, and smart interpretation capability for clinical imaging interpretation in enterprise imaging environments.
• Operations Suite Unified workspace for smart operations with RIS functionality, real-time workflow management, and streamlined operations across multi-site imaging center networks.
• TechLive Multi-modality, vendor-agnostic remote acquisition and collaboration platform that enables centralized operation and supervision of MR, CT, PET/CT, and ultrasound procedures through low-cost infrastructure, with a consolidated interface uniting console controls, patient monitoring, and injector visualization on a single screen.
• Breast Suite Comprehensive modular AI-powered suite for breast cancer detection and screening, including ProFound Pro cancer detection with automatic lesion localization and degree of suspicion, automated breast density assessment, risk stratification, and workflow acceleration supporting over 10 million mammograms annually.
• Prostate Suite AI-powered prostate cancer detection suite with automated lesion detection, risk classification, intelligent gland segmentation with PSA density calculation, and PI-RADS-compliant reporting, compatible with nine+ fusion biopsy systems.
• Chest Suite AI-powered lung cancer detection suite with pulmonary nodule detection, characterization, volumetric quantification, standardized reporting, and longitudinal tracking for lung cancer screening workflows.
• Neuro Suite AI-powered neuroimaging analysis suite for neurodegenerative disease assessment that automatically quantifies brain structures including hippocampus, cortical lobes, and subcortical regions, with a white matter hyperintensity (WMH) algorithm for automated quantification.
• Thyroid Suite AI-powered end-to-end solution for thyroid ultrasound imaging that automates nodule detection, characterization, measurements, and reporting within existing workflows; radiologists accepted AI-based measurements without correction in more than 94% of cases and reduces scan slot time by up to 30%.
• Reporting Pro AI-powered radiology report-creation tool that integrates speech recognition, clinical AI findings, measurements, AI-generated impressions, and quality assurance to improve radiologist productivity and report consistency.
• AI Studio Enterprise-grade AI orchestrator providing a unified platform for managing, routing, and monitoring AI tools; seamlessly orchestrates AI within clinical workflows and provides governance capabilities including AI validation, continuous monitoring, and drift management.
• SmartMammo AI-powered SaaS workflow and clinical solution for breast cancer screening that prioritizes cases based on suspicion level, embeds informatics into advanced mammography systems, and includes a cloud-native smart enterprise image viewer with PACS functionality and clinical AI detection tools.
• Patient Engagement Digital-first patient engagement platform that guides each patient from scheduling through preparation, registration, and follow-up, delivering a connected, patient-centered imaging experience.

Quantifiable outcome

• 21% increase in breast cancer detection rate (largest real-world analysis of AI-driven breast cancer screening in U.S. history, Nature Health study, 579,583 exams across 109 sites and 96 radiologists)
• +10 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability10 records

Feature14 records

Partnerships

Seven partnerships are on record, tiered core and supporting.

• Saint Alphonsus Health System (Trinity Health)coreStrategic or Co-development Partner · 30 April 2026RadNet and Trinity Health's Saint Alphonsus Health System formed a multi-site joint venture through acquisition of majority equity in Intermountain Medical Imaging, LLC. The joint venture operates five multi-modality imaging centers in Boise, Idaho. DeepHealth solutions (Diagnostics Suite, Reporting Pro, AI Studio, Clinical AI, Operations Suite) are deployed across all five centers, with Gem State Radiology providing professional radiology services using DeepHealth's technology. Projected to generate ~$30M annual revenue for RadNet.
• GE HealthCare (Expanded Collaboration)coreStrategic or Co-development Partner · 12 November 2025Expanded collaboration extends the initial 2024 GE HealthCare-DeepHealth partnership to include: global distribution of DeepHealth's Breast Suite including ProFound Pro and Safeguard Review; integration of DeepHealth's Thyroid Suite with GE HealthCare's ultrasound; and distribution of TechLive remote scanning with GE HealthCare's ultrasound products. The expanded collaboration was formalized via a Letter of Intent signed November 12, 2025, and further expanded in April 2026 to include international distribution of enhanced mammography AI tools.
• Siemens HealthineerscoreStrategic or Co-development Partner · 1 December 2024DeepHealth and Siemens Healthineers announced a strategic collaboration to transform ultrasound operations through SmartTechnology, embedding AI-powered health informatics within Siemens ultrasound workflows and imaging hardware. The collaboration aims to elevate ultrasound workflows with AI-powered automation, building on the GE HealthCare SmartTechnology framework.
• CARPL.aisupportingTechnology or Integration · 1 December 2024DeepHealth announced a strategic collaboration with CARPL.ai, a leading AI orchestration company, to use CARPL.ai's platform to develop a new AI control system for clinical AI performance and safety. The collaboration enables radiologists to access, assess, and integrate radiology AI solutions within their workflows, supporting DeepHealth's broader AI governance and orchestration capabilities.
• GE HealthCarecoreStrategic or Co-development Partner · 11 November 2024DeepHealth and GE HealthCare announced a strategic collaboration to develop SmartTechnology solutions combining DeepHealth's AI-powered health informatics with GE HealthCare's imaging technology. The initial focus united DeepHealth's SmartMammo AI workflow with GE HealthCare's Senographe Pristina mammography system. The collaboration was subsequently expanded to include global distribution of DeepHealth's Breast Suite with GE HealthCare's Pristina Via, integration of DeepHealth's Thyroid Suite with GE HealthCare's ultrasound imaging, and distribution of TechLive remote scanning with GE HealthCare's ultrasound portfolio. GE HealthCare distributes DeepHealth's solutions alongside its own mammography and ultrasound product lines.
• Incepto MedicalcoreStrategic or Co-development Partner · 28 February 2024DeepHealth and Incepto formed a strategic partnership to deliver expanded access to DeepHealth clinical AI and radiology informatics software across Europe. DeepHealth's technology (including DeepHealth OS and AI solutions) is made available through Incepto's curated portfolio. DeepHealth leverages Incepto's AI orchestration platform as part of DeepHealth OS and integrates Incepto-curated third-party AI solutions. Commercially, DeepHealth pilots Incepto's offering within its 366+ US imaging centers operated by parent RadNet. The partnership was announced at ECR 2024 in Vienna.
• RadNet / Trinity Health Joint VenturecoreStrategic or Co-development PartnerJoint venture between RadNet and Trinity Health's Saint Alphonsus Health System, representing a blueprint for future health system partnerships. RadNet brings operational, clinical, and digital workflow solutions to streamline the patient journey and improve medical care and outcomes. Multiple DeepHealth solutions are deployed across Saint Alphonsus Health System imaging centers.

Scale indicators17 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Viz.ai: Clinical AI company specializing in AI-powered care coordination and image analysis, with notable strength in stroke detection and expanding into other acute care AI. Competes with DeepHealth's neuro and chest imaging AI and targets overlapping hospital system buyers with similar enterprise SaaS economics.
• Aidoc: Israel-based clinical AI company offering AI-powered triage, detection, and workflow solutions for radiologists across CT and MRI. Directly competes with DeepHealth's clinical AI portfolio in hospital systems, with overlapping product categories in chest, neuro, and oncology AI applications.
• Lunit: South Korean radiology AI company with FDA-cleared and CE-marked solutions for breast cancer detection (Lunit INSIGHT MMG) and chest X-ray triage (Lunit INSIGHT CXR). Directly competes with DeepHealth's Breast Suite and Chest Suite products globally, including in the US and European screening program markets.
• Incepto Medical: European AI orchestration platform for medical imaging that curates and distributes third-party radiology AI solutions. DeepHealth is both a partner (integrating Incepto into DeepHealth OS) and a competitor in the AI orchestration layer across European hospital customers, creating overlapping platform plays.

Emerging players

• Riverain Technologies: Radiology AI company specializing in chest CT and X-ray AI for lung cancer detection and nodule management. Competes directly with DeepHealth's Chest Suite in thoracic imaging and lung cancer screening programs, particularly with US Department of Veterans Affairs and integrated delivery network customers.
• Annalise.ai: Australia-based radiology AI company offering comprehensive AI for chest X-ray and CT detection across many findings. Competes in overlapping clinical AI categories with DeepHealth's Chest Suite and Neuro Suite, with comparable enterprise SaaS distribution to hospital radiology departments.
• CARPL.ai: Radiology AI orchestration platform enabling access, assessment, and integration of multiple AI solutions. Partner of DeepHealth for AI control systems and governance, but also competes as an AI marketplace/orchestration alternative to DeepHealth OS / AI Studio, particularly for enterprise customers seeking vendor-neutral AI layers.

Broad incumbents

• Philips: Global healthcare technology incumbent operating the Precision Diagnosis division (MRI, CT, Ultrasound, Enterprise Diagnostic Informatics). Philips competes with DeepHealth across PACS/RIS (Vue PACS), clinical AI applications, and population health, and is the former employer of DeepHealth's CEO. Most direct comparable among broad incumbents given overlapping informatics and AI portfolios.
• GE HealthCare: One of the world's largest medical imaging equipment manufacturers and a DeepHealth strategic OEM partner. GE HealthCare's Edison platform and native AI applications compete with DeepHealth's clinical AI while also distributing it via Senographe Pristina and Pristina Via mammography systems, creating both partnership and competitive overlap.
• Siemens Healthineers: Major imaging OEM and DeepHealth strategic partner embedding SmartTechnology into its ultrasound portfolio. Siemens' AI-Rad Companion and broader Digital Health portfolio directly compete with DeepHealth's clinical AI applications across multiple modalities, while the OEM partnership provides distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/GEHealthCare
• LinkedInlinkedin.com/company/deephealthai

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DEEPHEALTH UK LIMITED